Neutrophil count improves the GRACE risk score prediction of clinical outcomes in patients with ST-elevation myocardial infarction

Atherosclerosis

Volumn 241, Issue 2, 2015, Pages 723-728

  Zhang, Sumei ^a   Wan, Zhaofei ^b   Zhang, Yongai ^a   Fan, Yan ^c   Gu, Wei ^d   Li, Fei ^a   Meng, Li ^a   Zeng, Xiaoyan ^e   Han, Dongfang ^e   Li, Xiaomei ^d  

^a XI'AN MEDICAL UNIVERSITY   (China)

^b SHAANXI PROVINCIAL PEOPLE S HOSPITAL   (China)

^c GANSU PROVINCIAL HOSPITAL   (China)

^d MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

^e THE FIRST AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

Neutrophil count; ST elevation myocardial infarction; The GRACE risk score

Indexed keywords

ADULT; ARTICLE; CARDIAC PATIENT; CARDIOVASCULAR DISEASE ASSESSMENT; CARDIOVASCULAR RISK; FEMALE; GLOBAL REGISTRY OF ACUTE CORONARY EVENTS RISK SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL COUNT; OUTCOME ASSESSMENT; PERFORMANCE MEASUREMENT SYSTEM; PREDICTION; PRIORITY JOURNAL; PROGNOSTIC ASSESSMENT; RISK ASSESSMENT; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; ACUTE CORONARY SYNDROME; AGED; BLOOD; CHINA; CLINICAL TRIAL; CYTOLOGY; FOLLOW UP; KAPLAN MEIER METHOD; LEUKOCYTE COUNT; MIDDLE AGED; MULTICENTER STUDY; MYOCARDIAL INFARCTION; NEUTROPHIL; PATHOPHYSIOLOGY; RECEIVER OPERATING CHARACTERISTIC; REGISTER; RISK FACTOR; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

ACUTE CORONARY SYNDROME; AGED; CHINA; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; LEUKOCYTE COUNT; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NEUTROPHILS; REGISTRIES; RISK FACTORS; ROC CURVE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84934975055     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2015.06.035     Document Type: Article

References (40)

1. Amin S.T., Morrow D.A., Braunwald E., Sloan S., Contant C., Murphy S., Antman E.M. Dynamic TIMI risk score for STEMI. J.Am. Heart Assoc. 2013, 2:e003269.
2. O'Gara P.T., Kushner F.G., Ascheim D.D., Casey D.E., Chung M.K., de Lemos J.A., Ettinger S.M., Fang J.C., Fesmire F.M., Franklin B.A. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American college of cardiology Foundation/American Heart association task force on practice guidelines. J.Am. Coll. Cardiol. 2013, 61:e78-e140.
3. Eagle K.A., Goodman S.G., Avezum Á., Budaj A., Sullivan C.M., López-Sendón J. Practice variation and missed opportunities for reperfusion in ST-segment-elevation myocardial infarction: findings from the Global Registry of Acute Coronary Events (GRACE). Lancet 2002, 359:373-377.
4. Tang E.W., Wong C.K., Herbison P. Global Registry of Acute Coronary Events (GRACE) hospital discharge risk score accurately predicts long-term mortality post acute coronary syndrome. Am. Heart J. 2007, 153:29-35.
5. Soehnlein O. Multiple roles for neutrophils in atherosclerosis. Circulation Res. 2012, 110:875-888.
6. Kim D.J., Noh J.H., Lee B.W., Choi Y.H., Chung J.H., Min Y.K., Lee M.S., Lee M.K., Kim K.W. The associations of total and differential white blood cell counts with obesity, hypertension, dyslipidemia and glucose intolerance in a Korean population. J.Korean Med. Sci. 2008, 23:193-198.
7. Naruko T., Ueda M., Haze K., van der Wal A.C., van der Loos C.M., Itoh A., Komatsu R., Ikura Y., Ogami M., Shimada Y. Neutrophil infiltration of culprit lesions in acute coronary syndromes. Circulation 2002, 106:2894-2900.
8. Carbone F., Nencioni A., Mach F., Vuilleumier N., Montecucco F. Pathophysiological role of neutrophils in acute myocardial infarction. Thromb. Haemost. 2013, 110:501-514.
9. Jordan J.E., Zhao Z.-Q., Vinten-Johansen J. The role of neutrophils in myocardial ischemia-reperfusion injury. Cardiovasc. Res. 1999, 43:860-878.
10. Dragu R., Khoury S., Zuckerman R., Suleiman M., Mutlak D., Agmon Y., Kapeliovich M., Beyar R., Markiewicz W., Hammerman H., Aronson D. Predictive value of white blood cell subtypes for long-term outcome following myocardial infarction. Atherosclerosis 2008, 196:405-412.
11. O'Donoghue M., Morrow D.A., Cannon C.P., Guo W., Murphy S.A., Gibson C.M., Sabatine M.S. Association between baseline neutrophil count, clopidogrel therapy, and clinical and angiographic outcomes in patients with ST-elevation myocardial infarction receiving fibrinolytic therapy. Eur. Heart J. 2008, 29:984-991.
12. Chia S., Nagurney J.T., Brown D.F., Raffel O.C., Bamberg F., Senatore F., Wackers F.J., Jang I.K. Association of leukocyte and neutrophil counts with infarct size, left ventricular function and outcomes after percutaneous coronary intervention for ST-elevation myocardial infarction. Am. J. Cardiol. 2009, 103:333-337.
13. Kyne L., Hausdorff J.M., Knight E., Dukas L., Azhar G., Wei J.Y. Neutrophilia and congestive heart failure after acute myocardial infarction. Am. Heart J. 2000, 139:94-100.
14. Antman E.M., Hand M., Armstrong P.W., Bates E.R., Green L.A., Halasyamani L.K., Hochman J.S., Krumholz H.M., Lamas G.A., Mullany C.J., Pearle D.L., Sloan M.A., Smith S.C., Writing Committee M., Anbe D.T., Kushner F.G., Ornato J.P., Jacobs A.K., Adams C.D., Anderson J.L., Buller C.E., Creager M.A., Ettinger S.M., Halperin J.L., Hunt S.A., Lytle B.W., Nishimura R., Page R.L., Riegel B., Tarkington L.G., Yancy C.W. 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration With the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction, Writing on Behalf of the 2004 Writing Committee. Circulation 2008, 117:296-329.
15. O'Hegarty M., Pederson L.L., Nelson D., Wortley P., Yenokyan G. Peer reviewed: young adults' perceptions of cigarette warning labels in the United States and Canada. Prev. Chronic Dis. 2007, 4.
16. Ford E.S. Prevalence of the metabolic syndrome defined by the international diabetes federation among adults in the US. Diabetes Care 2005, 28:2745-2749.
17. Mancia G., De Backer G., Dominiczak A., Cifkova R., Fagard R., Germano G., Grassi G., Heagerty A.M., Kjeldsen S.E., Laurent S. 2007 guidelines for the management of arterial hypertension the task force for the management of arterial Hypertension of the European society of Hypertension (ESH) and of the European society of cardiology (ESC). Eur. Heart J. 2007, 28:1462-1536.
18. Oncel R.C., Ucar M., Karakas M.S., Akdemir B., Yanikoglu A., Gulcan A.R., Altekin R.E., Demir I. Relation of neutrophil-to-Lymphocyte ratio with GRACE risk score to in-hospital cardiac events in patients with ST-Segment elevated myocardial infarction, clinical and applied thrombosis/hemostasis. Official J. Int. Acad. Clin. Appl. Thrombosis/Hemostasis 2015, 21:383-388.
19. Han S.W., Song W., Kim H.S., Shin K.S., Kang H., Cho H.C., Ki C.S., Park M.J. HMOX1 gene promoter polymorphism is not associated with coronary artery disease in Koreans. Ann. Laboratory Med. 2014, 34:337-344.
20. Rydén L., Standl E., Bartnik M., Van den Berghe G., Betteridge J., De Boer M.-J., Cosentino F., Jönsson B., Laakso M., Malmberg K. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary the task force on diabetes and cardiovascular diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur. Heart J. 2007, 28:88-136.
21. Granger C.B., Goldberg R.J., Dabbous O., Pieper K.S., Eagle K.A., Cannon C.P., Van de Werf F., Avezum A., Goodman S.G., Flather M.D. Predictors of hospital mortality in the global registry of acute coronary events. Archives Intern. Med. 2003, 163:2345-2353.
22. Eagle K.A., Lim M.J., Dabbous O.H., Pieper K.S., Goldberg R.J., Van de Werf F., Goodman S.G., Granger C.B., Steg P.G., Gore J.M. Avalidated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry. Jama 2004, 291:2727-2733.
23. DeLong E.R., DeLong D.M., Clarke-Pearson D.L. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988, 837-845.
24. D'Agostino R., Nam B.-H. Evaluation of the performance of survival analysis models: discrimination and calibration measures. Handbook of Statistics 2004, 23:1-25.
25. Pencina M.J., D'Agostino R.B., D'Agostino R.B., Vasan R.S. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Statistics Med. 2008, 27:157-172. discussion 207-112.
26. Morrow D.A., Antman E.M., Charlesworth A., Cairns R., Murphy S.A., de Lemos J.A., Giugliano R.P., McCabe C.H., Braunwald E. TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation an intravenous nPA for treatment of infarcting myocardium early II trial substudy. Circulation 2000, 102:2031-2037.
27. Halkin A., Singh M., Nikolsky E., Grines C.L., Tcheng J.E., Garcia E., Cox D.A., Turco M., Stuckey T.D., Na Y., Lansky A.J., Gersh B.J., O'Neill W.W., Mehran R., Stone G.W. Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: the CADILLAC risk score. J.Am. Coll. Cardiol. 2005, 45:1397-1405.
28. Tang E.W., Wong C.-K., Herbison P. Global Registry of Acute Coronary Events (GRACE) hospital discharge risk score accurately predicts long-term mortality post acute coronary syndrome. Am. Heart J. 2007, 153:29-35.
29. Kozieradzka A., Kaminski K.A., Maciorkowska D., Olszewska M., Dobrzycki S., Nowak K., Kralisz P., Prokopczuk P., Musial W.J. GRACE, TIMI, Zwolle and CADILLAC risk scores-do they predict 5-year outcomes after ST-elevation myocardial infarction treated invasively?. Int. J. Cardiol. 2011, 148:70-75.
30. Harris W.S., Kennedy K.F., O'Keefe J.H., Spertus J.A. Red blood cell fatty acid levels improve GRACE score prediction of 2-yr mortality in patients with myocardial infarction. Int. J. Cardiol. 2013, 168:53-59.
31. Wan Z.F., Zhou D., Xue J.H., Wu Y., Wang H., Zhao Y., Zhu L., Yuan Z.Y. Combination of mean platelet volume and the GRACE risk score better predicts future cardiovascular events in patients with acute coronary syndrome. Platelets 2014, 25:447-451.
32. Epstein F.H., Ross R. Atherosclerosis-an inflammatory disease. N.Engl. J. Med. 1999, 340:115-126.
33. Hansson G.K. Inflammation, atherosclerosis, and coronary artery disease. N.Engl. J. Med. 2005, 352:1685-1695.
34. Leclercq A., Houard X., Philippe M., Ollivier V., Sebbag U., Meilhac O., Michel J.B. Involvement of intraplaque hemorrhage in atherothrombosis evolution via neutrophil protease enrichment. J.Leukoc. Biol. 2007, 82:1420-1429.
35. Daugherty A., Dunn J.L., Rateri D.L., Heinecke J.W. Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J.Clin. Investig. 1994, 94:437.
36. Lucchesi B.R., Werns S.W., Fantone J.C. The role of the neutrophil and free radicals in ischemic myocardial injury. J.Mol. Cell. Cardiol. 1989, 21:1241-1251.
37. Jolly S.R., Kane W.J., Hook B.G., Abrams G.D., Kunkel S.L., Lucchesi B.R. Reduction of myocardial infarct size by neutrophil depletion: effect of duration of occlusion. Am. Heart J. 1986, 112:682-690.
38. Khan S.Q., Narayan H., Ng K.H., Dhillon O.S., Kelly D., Quinn P., Squire I.B., Davies J.E., Ng L.L. N-terminal pro-B-type natriuretic peptide complements the GRACE risk score in predicting early and late mortality following acute coronary syndrome. Clin. Sci. 2009, 117:31-39.
39. Schiele F., Meneveau N., Seronde M.F., Chopard R., Descotes-Genon V., Dutheil J., Bassand J.-P. C-reactive protein improves risk prediction in patients with acute coronary syndromes. Eur. Heart J. 2010, 31:290-297.
40. Widera C., Pencina M.J., Meisner A., Kempf T., Bethmann K., Marquardt I., Katus H.A., Giannitsis E., Wollert K.C. Adjustment of the GRACE score by growth differentiation factor 15 enables a more accurate appreciation of risk in non-ST-elevation acute coronary syndrome. Eur. Heart J. 2012, 33:1095-1104.